[{"id":"1bdfa3c5-3480-4494-ac29-f5c50d54ac49","acronym":"","url":"https://clinicaltrials.gov/study/NCT05214885","created_at":"2022-02-05T18:27:39.891Z","updated_at":"2024-07-02T16:36:15.793Z","phase":"","brief_title":"Novel Biomarkers of Hypoxia and Metabolism in Clear Cell Renal Cell Carcinoma","source_id_and_acronym":"NCT05214885","lead_sponsor":"Qianfoshan Hospital","biomarkers":" CA9 • NDUFA4L2 • EGLN3","pipe":" | ","alterations":" CA9 expression","tags":["CA9 • NDUFA4L2 • EGLN3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CA9 expression"],"overall_status":"Recruiting","enrollment":" Enrollment 300","initiation":"Initiation: 02/11/2022","start_date":" 02/11/2022","primary_txt":" Primary completion: 12/31/2025","primary_completion_date":" 12/31/2025","study_txt":" Completion: 12/31/2026","study_completion_date":" 12/31/2026","last_update_posted":"2022-03-09"}]